开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2166507, encodeId=f0a0216650ea6, content=中药复方类的大家有推荐？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0899046515, createdName=ms9000000849079540, createdTime=Fri Nov 03 15:45:26 CST 2023, time=2023-11-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2163898, encodeId=56d7216389823, content=european journal integrative medicine 这个杂志发表的文章无法在PUBMED里面检索吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Fri Oct 20 09:11:34 CST 2023, time=2023-10-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1207432, encodeId=edd5120e43201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：European Journal of Integrative Medicines 投稿的时候就要提供Cross check报告？哪位大神有投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b39c5222448, createdName=14781ff7m70暂无昵称, createdTime=Thu Mar 31 08:51:27 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579202, encodeId=e4fb5e9202aa, content=推荐审稿人邮箱怎么找啊Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c63d5193177, createdName=1471f8b3m47暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803176, encodeId=33f68031e675, content=审稿速度:6.0 | 投稿命中率:100.0 经验分享：垃圾杂志，门槛很低，老掉牙的干预都能发，怪不得IF不高呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200711/b0294d25be1d48528b91598f67b6513d/3879b137871441a4b87673852c13c707.png, createdBy=eb142473382, createdName=12441129m91(暂无昵称), createdTime=Sat Jul 18 09:41:07 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804701, encodeId=5fd5804e0170, content=各位小伙伴，论文在系统提交了，各位作者也确认了，但是系统显示当前论文状态是incomplete submission。请问这是没提交成功呢？我还需要做点啥呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c55402976, createdName=Lynne0222, createdTime=Mon Jul 27 09:32:46 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106232, encodeId=68692106232ca, content=请问大家都有推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc935640351, createdName=TCM small student, createdTime=Thu Dec 15 20:40:27 CST 2022, time=2022-12-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2097109, encodeId=fdfe209e109a5, content=偏重的研究方向：中药 经验分享：想请问一下欧洲综合医学杂志投稿时需要提交利益声明文件，但是提交后没有这个选项，一直投稿不成功怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Fri Oct 28 18:09:26 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237919, encodeId=05cd123e919a5, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c46479126, createdName=ms7000001613697897, createdTime=Wed Aug 10 20:53:17 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103735, encodeId=415c1103e352a, content=如何查找特定期刊要求的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-11-03 ms9000000849079540 来自黑龙江省

中药复方类的大家有推荐？

88 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166507, encodeId=f0a0216650ea6, content=中药复方类的大家有推荐？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0899046515, createdName=ms9000000849079540, createdTime=Fri Nov 03 15:45:26 CST 2023, time=2023-11-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2163898, encodeId=56d7216389823, content=european journal integrative medicine 这个杂志发表的文章无法在PUBMED里面检索吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Fri Oct 20 09:11:34 CST 2023, time=2023-10-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1207432, encodeId=edd5120e43201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：European Journal of Integrative Medicines 投稿的时候就要提供Cross check报告？哪位大神有投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b39c5222448, createdName=14781ff7m70暂无昵称, createdTime=Thu Mar 31 08:51:27 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579202, encodeId=e4fb5e9202aa, content=推荐审稿人邮箱怎么找啊Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c63d5193177, createdName=1471f8b3m47暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803176, encodeId=33f68031e675, content=审稿速度:6.0 | 投稿命中率:100.0 经验分享：垃圾杂志，门槛很低，老掉牙的干预都能发，怪不得IF不高呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200711/b0294d25be1d48528b91598f67b6513d/3879b137871441a4b87673852c13c707.png, createdBy=eb142473382, createdName=12441129m91(暂无昵称), createdTime=Sat Jul 18 09:41:07 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804701, encodeId=5fd5804e0170, content=各位小伙伴，论文在系统提交了，各位作者也确认了，但是系统显示当前论文状态是incomplete submission。请问这是没提交成功呢？我还需要做点啥呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c55402976, createdName=Lynne0222, createdTime=Mon Jul 27 09:32:46 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106232, encodeId=68692106232ca, content=请问大家都有推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc935640351, createdName=TCM small student, createdTime=Thu Dec 15 20:40:27 CST 2022, time=2022-12-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2097109, encodeId=fdfe209e109a5, content=偏重的研究方向：中药 经验分享：想请问一下欧洲综合医学杂志投稿时需要提交利益声明文件，但是提交后没有这个选项，一直投稿不成功怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Fri Oct 28 18:09:26 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237919, encodeId=05cd123e919a5, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c46479126, createdName=ms7000001613697897, createdTime=Wed Aug 10 20:53:17 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103735, encodeId=415c1103e352a, content=如何查找特定期刊要求的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-10-20 ms4000000339340254 来自湖南省

european journal integrative medicine 这个杂志发表的文章无法在PUBMED里面检索吗

72 0

[GetPortalCommentsPageByObjectIdResponse(id=2166507, encodeId=f0a0216650ea6, content=中药复方类的大家有推荐？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0899046515, createdName=ms9000000849079540, createdTime=Fri Nov 03 15:45:26 CST 2023, time=2023-11-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2163898, encodeId=56d7216389823, content=european journal integrative medicine 这个杂志发表的文章无法在PUBMED里面检索吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Fri Oct 20 09:11:34 CST 2023, time=2023-10-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1207432, encodeId=edd5120e43201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：European Journal of Integrative Medicines 投稿的时候就要提供Cross check报告？哪位大神有投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b39c5222448, createdName=14781ff7m70暂无昵称, createdTime=Thu Mar 31 08:51:27 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579202, encodeId=e4fb5e9202aa, content=推荐审稿人邮箱怎么找啊Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c63d5193177, createdName=1471f8b3m47暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803176, encodeId=33f68031e675, content=审稿速度:6.0 | 投稿命中率:100.0 经验分享：垃圾杂志，门槛很低，老掉牙的干预都能发，怪不得IF不高呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200711/b0294d25be1d48528b91598f67b6513d/3879b137871441a4b87673852c13c707.png, createdBy=eb142473382, createdName=12441129m91(暂无昵称), createdTime=Sat Jul 18 09:41:07 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804701, encodeId=5fd5804e0170, content=各位小伙伴，论文在系统提交了，各位作者也确认了，但是系统显示当前论文状态是incomplete submission。请问这是没提交成功呢？我还需要做点啥呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c55402976, createdName=Lynne0222, createdTime=Mon Jul 27 09:32:46 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106232, encodeId=68692106232ca, content=请问大家都有推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc935640351, createdName=TCM small student, createdTime=Thu Dec 15 20:40:27 CST 2022, time=2022-12-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2097109, encodeId=fdfe209e109a5, content=偏重的研究方向：中药 经验分享：想请问一下欧洲综合医学杂志投稿时需要提交利益声明文件，但是提交后没有这个选项，一直投稿不成功怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Fri Oct 28 18:09:26 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237919, encodeId=05cd123e919a5, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c46479126, createdName=ms7000001613697897, createdTime=Wed Aug 10 20:53:17 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103735, encodeId=415c1103e352a, content=如何查找特定期刊要求的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-03-31 14781ff7m70暂无昵称

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：中药
经验分享：European Journal of Integrative Medicines 投稿的时候就要提供Cross check报告？哪位大神有投稿经验？

104 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166507, encodeId=f0a0216650ea6, content=中药复方类的大家有推荐？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0899046515, createdName=ms9000000849079540, createdTime=Fri Nov 03 15:45:26 CST 2023, time=2023-11-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2163898, encodeId=56d7216389823, content=european journal integrative medicine 这个杂志发表的文章无法在PUBMED里面检索吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Fri Oct 20 09:11:34 CST 2023, time=2023-10-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1207432, encodeId=edd5120e43201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：European Journal of Integrative Medicines 投稿的时候就要提供Cross check报告？哪位大神有投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b39c5222448, createdName=14781ff7m70暂无昵称, createdTime=Thu Mar 31 08:51:27 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579202, encodeId=e4fb5e9202aa, content=推荐审稿人邮箱怎么找啊Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c63d5193177, createdName=1471f8b3m47暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803176, encodeId=33f68031e675, content=审稿速度:6.0 | 投稿命中率:100.0 经验分享：垃圾杂志，门槛很低，老掉牙的干预都能发，怪不得IF不高呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200711/b0294d25be1d48528b91598f67b6513d/3879b137871441a4b87673852c13c707.png, createdBy=eb142473382, createdName=12441129m91(暂无昵称), createdTime=Sat Jul 18 09:41:07 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804701, encodeId=5fd5804e0170, content=各位小伙伴，论文在系统提交了，各位作者也确认了，但是系统显示当前论文状态是incomplete submission。请问这是没提交成功呢？我还需要做点啥呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c55402976, createdName=Lynne0222, createdTime=Mon Jul 27 09:32:46 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106232, encodeId=68692106232ca, content=请问大家都有推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc935640351, createdName=TCM small student, createdTime=Thu Dec 15 20:40:27 CST 2022, time=2022-12-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2097109, encodeId=fdfe209e109a5, content=偏重的研究方向：中药 经验分享：想请问一下欧洲综合医学杂志投稿时需要提交利益声明文件，但是提交后没有这个选项，一直投稿不成功怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Fri Oct 28 18:09:26 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237919, encodeId=05cd123e919a5, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c46479126, createdName=ms7000001613697897, createdTime=Wed Aug 10 20:53:17 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103735, encodeId=415c1103e352a, content=如何查找特定期刊要求的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2019-11-01 1471f8b3m47暂无昵称

推荐审稿人邮箱怎么找啊Yuen 2019-07-30 00:00:00 发表:
Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019

Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019

210 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166507, encodeId=f0a0216650ea6, content=中药复方类的大家有推荐？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0899046515, createdName=ms9000000849079540, createdTime=Fri Nov 03 15:45:26 CST 2023, time=2023-11-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2163898, encodeId=56d7216389823, content=european journal integrative medicine 这个杂志发表的文章无法在PUBMED里面检索吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Fri Oct 20 09:11:34 CST 2023, time=2023-10-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1207432, encodeId=edd5120e43201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：European Journal of Integrative Medicines 投稿的时候就要提供Cross check报告？哪位大神有投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b39c5222448, createdName=14781ff7m70暂无昵称, createdTime=Thu Mar 31 08:51:27 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579202, encodeId=e4fb5e9202aa, content=推荐审稿人邮箱怎么找啊Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c63d5193177, createdName=1471f8b3m47暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803176, encodeId=33f68031e675, content=审稿速度:6.0 | 投稿命中率:100.0 经验分享：垃圾杂志，门槛很低，老掉牙的干预都能发，怪不得IF不高呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200711/b0294d25be1d48528b91598f67b6513d/3879b137871441a4b87673852c13c707.png, createdBy=eb142473382, createdName=12441129m91(暂无昵称), createdTime=Sat Jul 18 09:41:07 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804701, encodeId=5fd5804e0170, content=各位小伙伴，论文在系统提交了，各位作者也确认了，但是系统显示当前论文状态是incomplete submission。请问这是没提交成功呢？我还需要做点啥呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c55402976, createdName=Lynne0222, createdTime=Mon Jul 27 09:32:46 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106232, encodeId=68692106232ca, content=请问大家都有推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc935640351, createdName=TCM small student, createdTime=Thu Dec 15 20:40:27 CST 2022, time=2022-12-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2097109, encodeId=fdfe209e109a5, content=偏重的研究方向：中药 经验分享：想请问一下欧洲综合医学杂志投稿时需要提交利益声明文件，但是提交后没有这个选项，一直投稿不成功怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Fri Oct 28 18:09:26 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237919, encodeId=05cd123e919a5, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c46479126, createdName=ms7000001613697897, createdTime=Wed Aug 10 20:53:17 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103735, encodeId=415c1103e352a, content=如何查找特定期刊要求的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2020-07-18 12441129m91(暂无昵称)

审稿速度:6.0 | 投稿命中率:100.0
经验分享：垃圾杂志，门槛很低，老掉牙的干预都能发，怪不得IF不高呢

172 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166507, encodeId=f0a0216650ea6, content=中药复方类的大家有推荐？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0899046515, createdName=ms9000000849079540, createdTime=Fri Nov 03 15:45:26 CST 2023, time=2023-11-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2163898, encodeId=56d7216389823, content=european journal integrative medicine 这个杂志发表的文章无法在PUBMED里面检索吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Fri Oct 20 09:11:34 CST 2023, time=2023-10-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1207432, encodeId=edd5120e43201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：European Journal of Integrative Medicines 投稿的时候就要提供Cross check报告？哪位大神有投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b39c5222448, createdName=14781ff7m70暂无昵称, createdTime=Thu Mar 31 08:51:27 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579202, encodeId=e4fb5e9202aa, content=推荐审稿人邮箱怎么找啊Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c63d5193177, createdName=1471f8b3m47暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803176, encodeId=33f68031e675, content=审稿速度:6.0 | 投稿命中率:100.0 经验分享：垃圾杂志，门槛很低，老掉牙的干预都能发，怪不得IF不高呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200711/b0294d25be1d48528b91598f67b6513d/3879b137871441a4b87673852c13c707.png, createdBy=eb142473382, createdName=12441129m91(暂无昵称), createdTime=Sat Jul 18 09:41:07 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804701, encodeId=5fd5804e0170, content=各位小伙伴，论文在系统提交了，各位作者也确认了，但是系统显示当前论文状态是incomplete submission。请问这是没提交成功呢？我还需要做点啥呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c55402976, createdName=Lynne0222, createdTime=Mon Jul 27 09:32:46 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106232, encodeId=68692106232ca, content=请问大家都有推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc935640351, createdName=TCM small student, createdTime=Thu Dec 15 20:40:27 CST 2022, time=2022-12-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2097109, encodeId=fdfe209e109a5, content=偏重的研究方向：中药 经验分享：想请问一下欧洲综合医学杂志投稿时需要提交利益声明文件，但是提交后没有这个选项，一直投稿不成功怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Fri Oct 28 18:09:26 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237919, encodeId=05cd123e919a5, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c46479126, createdName=ms7000001613697897, createdTime=Wed Aug 10 20:53:17 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103735, encodeId=415c1103e352a, content=如何查找特定期刊要求的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2020-07-27 Lynne0222

各位小伙伴，论文在系统提交了，各位作者也确认了，但是系统显示当前论文状态是incomplete submission。请问这是没提交成功呢？我还需要做点啥呀？

168 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166507, encodeId=f0a0216650ea6, content=中药复方类的大家有推荐？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0899046515, createdName=ms9000000849079540, createdTime=Fri Nov 03 15:45:26 CST 2023, time=2023-11-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2163898, encodeId=56d7216389823, content=european journal integrative medicine 这个杂志发表的文章无法在PUBMED里面检索吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Fri Oct 20 09:11:34 CST 2023, time=2023-10-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1207432, encodeId=edd5120e43201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：European Journal of Integrative Medicines 投稿的时候就要提供Cross check报告？哪位大神有投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b39c5222448, createdName=14781ff7m70暂无昵称, createdTime=Thu Mar 31 08:51:27 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579202, encodeId=e4fb5e9202aa, content=推荐审稿人邮箱怎么找啊Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c63d5193177, createdName=1471f8b3m47暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803176, encodeId=33f68031e675, content=审稿速度:6.0 | 投稿命中率:100.0 经验分享：垃圾杂志，门槛很低，老掉牙的干预都能发，怪不得IF不高呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200711/b0294d25be1d48528b91598f67b6513d/3879b137871441a4b87673852c13c707.png, createdBy=eb142473382, createdName=12441129m91(暂无昵称), createdTime=Sat Jul 18 09:41:07 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804701, encodeId=5fd5804e0170, content=各位小伙伴，论文在系统提交了，各位作者也确认了，但是系统显示当前论文状态是incomplete submission。请问这是没提交成功呢？我还需要做点啥呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c55402976, createdName=Lynne0222, createdTime=Mon Jul 27 09:32:46 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106232, encodeId=68692106232ca, content=请问大家都有推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc935640351, createdName=TCM small student, createdTime=Thu Dec 15 20:40:27 CST 2022, time=2022-12-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2097109, encodeId=fdfe209e109a5, content=偏重的研究方向：中药 经验分享：想请问一下欧洲综合医学杂志投稿时需要提交利益声明文件，但是提交后没有这个选项，一直投稿不成功怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Fri Oct 28 18:09:26 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237919, encodeId=05cd123e919a5, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c46479126, createdName=ms7000001613697897, createdTime=Wed Aug 10 20:53:17 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103735, encodeId=415c1103e352a, content=如何查找特定期刊要求的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-12-15 TCM small student 来自吉林省

请问大家都有推荐审稿人吗？

93 0

[GetPortalCommentsPageByObjectIdResponse(id=2166507, encodeId=f0a0216650ea6, content=中药复方类的大家有推荐？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0899046515, createdName=ms9000000849079540, createdTime=Fri Nov 03 15:45:26 CST 2023, time=2023-11-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2163898, encodeId=56d7216389823, content=european journal integrative medicine 这个杂志发表的文章无法在PUBMED里面检索吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Fri Oct 20 09:11:34 CST 2023, time=2023-10-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1207432, encodeId=edd5120e43201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：European Journal of Integrative Medicines 投稿的时候就要提供Cross check报告？哪位大神有投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b39c5222448, createdName=14781ff7m70暂无昵称, createdTime=Thu Mar 31 08:51:27 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579202, encodeId=e4fb5e9202aa, content=推荐审稿人邮箱怎么找啊Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c63d5193177, createdName=1471f8b3m47暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803176, encodeId=33f68031e675, content=审稿速度:6.0 | 投稿命中率:100.0 经验分享：垃圾杂志，门槛很低，老掉牙的干预都能发，怪不得IF不高呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200711/b0294d25be1d48528b91598f67b6513d/3879b137871441a4b87673852c13c707.png, createdBy=eb142473382, createdName=12441129m91(暂无昵称), createdTime=Sat Jul 18 09:41:07 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804701, encodeId=5fd5804e0170, content=各位小伙伴，论文在系统提交了，各位作者也确认了，但是系统显示当前论文状态是incomplete submission。请问这是没提交成功呢？我还需要做点啥呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c55402976, createdName=Lynne0222, createdTime=Mon Jul 27 09:32:46 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106232, encodeId=68692106232ca, content=请问大家都有推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc935640351, createdName=TCM small student, createdTime=Thu Dec 15 20:40:27 CST 2022, time=2022-12-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2097109, encodeId=fdfe209e109a5, content=偏重的研究方向：中药 经验分享：想请问一下欧洲综合医学杂志投稿时需要提交利益声明文件，但是提交后没有这个选项，一直投稿不成功怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Fri Oct 28 18:09:26 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237919, encodeId=05cd123e919a5, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c46479126, createdName=ms7000001613697897, createdTime=Wed Aug 10 20:53:17 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103735, encodeId=415c1103e352a, content=如何查找特定期刊要求的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-10-28 ms5000001622730751

偏重的研究方向：中药
经验分享：想请问一下欧洲综合医学杂志投稿时需要提交利益声明文件，但是提交后没有这个选项，一直投稿不成功怎么办

95 0

[GetPortalCommentsPageByObjectIdResponse(id=2166507, encodeId=f0a0216650ea6, content=中药复方类的大家有推荐？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0899046515, createdName=ms9000000849079540, createdTime=Fri Nov 03 15:45:26 CST 2023, time=2023-11-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2163898, encodeId=56d7216389823, content=european journal integrative medicine 这个杂志发表的文章无法在PUBMED里面检索吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Fri Oct 20 09:11:34 CST 2023, time=2023-10-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1207432, encodeId=edd5120e43201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：European Journal of Integrative Medicines 投稿的时候就要提供Cross check报告？哪位大神有投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b39c5222448, createdName=14781ff7m70暂无昵称, createdTime=Thu Mar 31 08:51:27 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579202, encodeId=e4fb5e9202aa, content=推荐审稿人邮箱怎么找啊Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c63d5193177, createdName=1471f8b3m47暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803176, encodeId=33f68031e675, content=审稿速度:6.0 | 投稿命中率:100.0 经验分享：垃圾杂志，门槛很低，老掉牙的干预都能发，怪不得IF不高呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200711/b0294d25be1d48528b91598f67b6513d/3879b137871441a4b87673852c13c707.png, createdBy=eb142473382, createdName=12441129m91(暂无昵称), createdTime=Sat Jul 18 09:41:07 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804701, encodeId=5fd5804e0170, content=各位小伙伴，论文在系统提交了，各位作者也确认了，但是系统显示当前论文状态是incomplete submission。请问这是没提交成功呢？我还需要做点啥呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c55402976, createdName=Lynne0222, createdTime=Mon Jul 27 09:32:46 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106232, encodeId=68692106232ca, content=请问大家都有推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc935640351, createdName=TCM small student, createdTime=Thu Dec 15 20:40:27 CST 2022, time=2022-12-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2097109, encodeId=fdfe209e109a5, content=偏重的研究方向：中药 经验分享：想请问一下欧洲综合医学杂志投稿时需要提交利益声明文件，但是提交后没有这个选项，一直投稿不成功怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Fri Oct 28 18:09:26 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237919, encodeId=05cd123e919a5, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c46479126, createdName=ms7000001613697897, createdTime=Wed Aug 10 20:53:17 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103735, encodeId=415c1103e352a, content=如何查找特定期刊要求的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-08-10 ms7000001613697897

审稿速度:2.0 | 投稿命中率:75.0
经验分享：无

85 0

[GetPortalCommentsPageByObjectIdResponse(id=2166507, encodeId=f0a0216650ea6, content=中药复方类的大家有推荐？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0899046515, createdName=ms9000000849079540, createdTime=Fri Nov 03 15:45:26 CST 2023, time=2023-11-03, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2163898, encodeId=56d7216389823, content=european journal integrative medicine 这个杂志发表的文章无法在PUBMED里面检索吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5865456063, createdName=ms4000000339340254, createdTime=Fri Oct 20 09:11:34 CST 2023, time=2023-10-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1207432, encodeId=edd5120e43201, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：European Journal of Integrative Medicines 投稿的时候就要提供Cross check报告？哪位大神有投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b39c5222448, createdName=14781ff7m70暂无昵称, createdTime=Thu Mar 31 08:51:27 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579202, encodeId=e4fb5e9202aa, content=推荐审稿人邮箱怎么找啊Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=Yuen 2019-07-30 00:00:00 发表: Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c63d5193177, createdName=1471f8b3m47暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803176, encodeId=33f68031e675, content=审稿速度:6.0 | 投稿命中率:100.0 经验分享：垃圾杂志，门槛很低，老掉牙的干预都能发，怪不得IF不高呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200711/b0294d25be1d48528b91598f67b6513d/3879b137871441a4b87673852c13c707.png, createdBy=eb142473382, createdName=12441129m91(暂无昵称), createdTime=Sat Jul 18 09:41:07 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804701, encodeId=5fd5804e0170, content=各位小伙伴，论文在系统提交了，各位作者也确认了，但是系统显示当前论文状态是incomplete submission。请问这是没提交成功呢？我还需要做点啥呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63c55402976, createdName=Lynne0222, createdTime=Mon Jul 27 09:32:46 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106232, encodeId=68692106232ca, content=请问大家都有推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc935640351, createdName=TCM small student, createdTime=Thu Dec 15 20:40:27 CST 2022, time=2022-12-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2097109, encodeId=fdfe209e109a5, content=偏重的研究方向：中药 经验分享：想请问一下欧洲综合医学杂志投稿时需要提交利益声明文件，但是提交后没有这个选项，一直投稿不成功怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Fri Oct 28 18:09:26 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237919, encodeId=05cd123e919a5, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c46479126, createdName=ms7000001613697897, createdTime=Wed Aug 10 20:53:17 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103735, encodeId=415c1103e352a, content=如何查找特定期刊要求的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 MS54455111222

如何查找特定期刊要求的格式？

108 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务